The R&D of advanced collection kits requires appropriate infrastructure, a controlled environment, and a pool of experts. Additionally, the kits require highly skilled and trained staff to operate under quality assurance protocols. The lack of these facilities in emerging countries is expected to deter market growth over the next few years. Many sites around the MEA are providing proper training and are concerned that inadequate swab collection may continue to lead to false-negative results. The rate of false-negative results in reverse transcriptase-polymerase chain reaction testing is a great concern because it underestimates the prevalence of SARS-CoV-2 infection, gives a false sense of security to patients and the health care workers caring for them, and limits public health efforts in identifying and tracking the spread of the virus.
Professionals are highlighting the exact collection position through awareness campaigns, which can help limit false-negative results in testing for SARS-CoV-2 and other respiratory viruses. Moreover, according to a report published by JAMA Otolaryngology-Head & Neck Surgery in September 2020, a nasopharyngeal swab test (NPS Test) is uncomfortable, and sometimes it can cause severe pain. Such discomfort indicates to the operator that an anatomical obstruction, such as a deviated septum, is obstructing the pathway, and a modified trajectory or contralateral approach should be attempted.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA swabs collection kit market at a good CAGR during the forecast period.
MEA swabs collection kit Market Segmentation
The MEA swabs collection kit market is analyzed on the basis of type, application, and country. Based on type, the market is segmented into nasopharyngeal swabs, oropharyngeal swabs, and others. The nasopharyngeal swabs dominated the market in 2020. Based on application, the market is segmented into microbiology laboratories, diagnostic laboratories, hospitals and clinics, home tests, and others. The hospitals and clinics segment dominated the market in 2020.
Based on country, the MEA swabs collection kit market is segmented into Saudi Arabia, South Africa, UAE, and the Rest of MEA. The UAE dominated the MEA swabs collection kit market in 2020.
BD; Puritan Medical Products Company LLC; Laboratory Corporation of America Holdings; HiMedia Laboratories; THERMO FISHER SCIENTIFIC INC.; Hardy Diagnostics; VIRCELL SL; BTNX, Inc; Formlabs; Quidel Corporation; DiaSorin S.P.A; Norgen Biotek Corp; Hologic, Inc; Quest Diagnostics Incorporated; Abbott; Lynn Peavey Company; and QIAGEN by Altair are the leading companies in the MEA swabs collection kit market.